Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Stillpoint- re: shareholder action
11
Sep 21, 2010 12:07PM

Actually your reply does not answer my concerns. You began this thread and this debate by suggesting a shareholder derivative action might be a productive "option" for PTSC shareholders. I would simply appreciate answers to the questions I posed previously below. If you don't have the answers that's fine. Just say so. Thanks.

How does posting an article about a "shareholder derivative action" on a public message board which is - who are we kidding here? - really just a thinly-veiled threat to the board of PTSC- how does this kind of thing increase shareholder value? I would think it would have the opposite of the intended effect and there will surely be a net short term and long term lowering of the share price as potential investors would not touch such an investment with the proverbial ten foot pole.

Also-please post the amount the lawyers received (percentage or lump sum-either would suffice) in your example and please post the amount per share or overall percentage of the settlement amount shareholders received in your example. Your answers should be interesting!

Your sincere reply would be appreciated. Thank you.

Share
New Message
Please login to post a reply